---
title: "SPUR THERAPEUTICS HOLDINGS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/72ad03df-675f-5729-9f5a-d4dfc0b779b8
json: https://whiteintel.dev/api/public/dossier/72ad03df-675f-5729-9f5a-d4dfc0b779b8
identifier: oo:GB-COH-15295548
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SPUR THERAPEUTICS HOLDINGS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-15295548`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/72ad03df-675f-5729-9f5a-d4dfc0b779b8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/72ad03df-675f-5729-9f5a-d4dfc0b779b8  

## Ownership & control

### Owners / controllers

- **Syncona Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/469c21c8-5340-404b-bed0-49a97f8dde35

### Holdings / subsidiaries

- **SWANBIO THERAPEUTICS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/424ddea0-a606-52f1-abd8-c1c439be1f4f
- **FREELINE THERAPEUTICS HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/654fc085-b04b-5b8e-96a4-f48cdb0aa490
- **SWANBIO THERAPEUTICS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/424ddea0-a606-52f1-abd8-c1c439be1f4f
- **SPUR THERAPEUTICS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/60c716e3-83a8-5fd3-b7a8-3a2ce49a81b9

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `15295548`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2023-11-20
- **Registered office:** Sycamore House, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2BP, England
- **SIC:** 64209

### Officers

- MCCORKLE IV, Pope "Chip" — secretary · appointed 2024-04-05
- HOLLOWOOD, Christopher John, Dr — director · British · appointed 2024-02-29
- COSSAR, Andrew — director · British · appointed 2023-11-20 · resigned 2024-02-29
- HAMILTON, Alexander Brian, Dr — director · British · appointed 2023-11-20 · resigned 2024-02-29
- PARINI, Michael John — director · American · appointed 2024-02-29 · resigned 2026-07-31
- TSAI, John, Dr — director · American · appointed 2024-04-30 · resigned 2026-01-31

### Beneficial owners (Persons with Significant Control)

- [Syncona Limited](https://whiteintel.dev/entity/469c21c8-5340-404b-bed0-49a97f8dde35) — 75–100% shares · corporate PSC · Guernsey — since 2023-11-20

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/15295548
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/15295548

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **SPUR THERAPEUTICS HOLDINGS LIMITED** — https://whiteintel.dev/entity/72ad03df-675f-5729-9f5a-d4dfc0b779b8 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SPUR THERAPEUTICS HOLDINGS LIMITED**. Human view: https://whiteintel.dev/entity/72ad03df-675f-5729-9f5a-d4dfc0b779b8 · Structured JSON: https://whiteintel.dev/api/public/dossier/72ad03df-675f-5729-9f5a-d4dfc0b779b8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._